INTRODUCTION
The clinical significance of Human Cytomegalovirus (HCMV) had been reported increasingly in the past two decades. It was reported that over 70% of the populations are proved to be carriers of HCMV [1] and it is established as one of the causes of both co-morbidity and may be fatality in immunocompromised individuals
Cytomegalovirus is a ubiquitous bherpes virus family which affects 60-80% of humans. Infection with CMV is more prevalent in the developing countries and usually controlled by the immune system without eradication. Instead, the virus remains in a latent state but reactivation may occur [3] .
Reactivation may occur during times where the immune system is suppressed, by drugs, acute illness states, and other inflammatory diseases, or super infection by different pathogens [4, 5] .
Viral interactions were reported to affect the pathogenesis of other viral infections [6] . Studies concluded that HCV and HBV co-infection exist and can suppress the replication of each other [7] . Co-infections with HBV and HIV in patients with HCV have been documented and was associated more progressive course of HCV and more aggressive histological changes enhancing the progression to cirrhosis and HCC [8] . Few studies investigated the co-incidence of CMV and chronic HCV [5] .
It was reported that CMV infection had occurred with HBV and HCV patients and it was associated with a progressive form of chronic HCV. Bader El-Din et al. [9] reported that CMV HCV co-infection was higher among Egyptian patients than other populations. This study aimed to determine the prevalence of HCMV co-infection in patients with chronic HCV and its correlation with HCV viral load in both Clinical Pathology and the Tropical Medicine department, Faculty of Medicine, Zagazig University. 
PATIENTS AND METHODS

II-Methods
Both patients and control were subjected to • Full medical history taking.
• Routine laboratory investigations.
-Complete Blood Picture.
-Liver function tests: -Serum albumin -Serum bilirubin -Serum total protein -ALT, AST and Alkaline phosphatase.
• Random blood glucose level.
• HCV Abs.
• Quantitative PCR for HCV RNA for (patient group).
• HCMV IgG and IgM in serum by Enzyme linked immune assay (ELISA).
• Pelvi-abdominal ultrasonography.
Statistical analysis
Data were checked, entered and analyzed using SPSS 17 for Windows. Data were expressed as mean ± SD for quantitative variable, number and percentage for qualitative one. Chi-squared (X 2 ) or t test and paired t test were used when appropriate. P < 0.05 was considered significant < 0.001 was considered highly significant.
RESULTS
Demographic data showed that there was nonsignificant difference between cases and control group as regard gender and age (P>0.05) ( Table  1 ). There was highly statistically significant difference in WBCs, RBCs and Platelets among cases and controls. No significance was found in HB, Lymph., Gran., and MID. among cases and controls (Table 2 ). There were significant differences in values of ALT, AST and ALP between resolved cases and the other patient subgroups (Table 3) . A comparative study of CMV Abs among cases and controls revealing that there was a statistically significant difference between cases and controls as regards IgG CMV Abs. There was no statistical significant difference between cases and control as regards IgM CMV Abs (Table 4 ). There was no significant difference in IgG and IgM antibodies (Table 5 ). However, there was no correlation between PCR and IgG but there was +ve significant correlation between PCR and IgM (Table 6 ). There was no correlation between PCR and IgG in all subgroups also no correlation between PCR and IgM in mild and moderate cases but there was positive significant correlation between PCR and IgM in severe cases (Table 7) . We found that ALT, AST and ALP levels were higher in patients than in the control group with significance. It was also found that ALT, AST and ALP levels were significantly higher in other patient subgroups than in the resolved patient subgroup. These findings were in agreement with the finding of Tabll et al.
[3] where they reported that both ALT and AST levels were higher in the HCV persistent group than in the spontaneously cleared group and that there was no difference between the spontaneously cleared group and the control group but there were no comments on ALP levels in their study.
Also, there were a high percentage of CMV IgM antibodies among patients group (28.3%) than in the control group (16.7%). This was an agreement with Tabll et al.
[3] where they stated that the prevalence of HCMV Abs (IgG & IgM) were higher in chronic HCV patients than in control subjects. In their study the patient group showed that 87% of patients were positive for IgG and 25% were positive for HCMV IgM, whereas their control group was 53% and 17.6% respectively, stating that the prevalence of positive CMV IgG and IgM antibodies was significantly higher in chronic HCV patients than those in spontaneously cleared HCV patients. These findings suggest that HCMV infection in chronic HCV patients has a direct effect on the activity of ALT and AST enzymes by increasing their levels in serum.
Serum total bilirubin levels were also elevated among patients compared to controls and the difference was statistically significant. 
CONCLUSION
From the presented data, we can conclude that CMV infection is common in chronic HCV patients and there was no correlation between hepatitis C virus load and CMV IgG but there was positive significant correlation between hepatitis C virus load and CMV IgM. There was no correlation between hepatitis C virus load and CMV IgG in all patients subgroups also no correlation between hepatitis C virus load and CMV IgM in mild and moderate cases but there was positive significant correlation between hepatitis C virus load and CMV IgM in severe cases. Also, the significant elevation in the serum activity levels of ALT and AST in HCMV/HCV patients than in HCMV patients only, reflects the severity of liver inflammation in HCMV infected chronic HCV patient.
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